London Daily
London Daily News
Tuesday, Jan 18, 2022
LondOn!
UK
Health
Business
Technology
Add Your News
AstraZeneca
Rare condition listed as possible side effect of Covid-19 shots
The EU’s drug watchdog is warning of a ‘very rare’ spinal cord inflammation possibly related to the AstraZeneca and J&J vaccines
US Revives Lawsuit Against Pfizer, AstraZeneca Over Iraq Terror Funding
The US court plaintiffs contend that the terrorist group Jaysh al-Mahdi controlled Iraq's health ministry and that 21 defendant medical companies, including AstraZeneca and Pfizer, made corrupt payments to obtain medical-supply contracts.
UK Fears Hospital Crisis As Covid Cases Cross 200,000 For First Time
UK's 24-hour tally, after chalking up multiple records in the run-up to New Year, hit 218,724 and another 48 deaths were reported in the latest government data.
'We can't vaccinate the planet every six months,' says Oxford vaccine scientist
A leading expert who helped create the Oxford-AstraZeneca Covid-19 vaccine said Tuesday that giving everyone in the world booster shots multiple times a year is not feasible.
Omicron: When can I have a booster jab and how do I book one?
The New Year booster target has been met across the UK, according to government ministers.
Why some people don't want a Covid-19 vaccine
Social media is rife with posts disparaging the vaccine hesitant – but these reactions to a complex and nuanced issue are doing more harm than good.
US Health Regulator Authorizes Pfizer's Covid Pill
Pfizer's treatment, called Paxlovid, is a combination of two pills taken over five days that was shown in a clinical trial of 2,200 people to be safe and reduced the risk of hospitalizations and deaths among at-risk people by 88 percent.
Oxford, AstraZeneca launch work on Omicron-targeted vaccine
AstraZeneca Plc (AZN.L) said on Tuesday it is working with Oxford University to produce a vaccine for the Omicron coronavirus variant, joining other vaccine-makers who are looking to develop the variant-specific vaccine.
WHO Approves Novavax As 10th Authorised Covid Jab
Nuvaxovid uses a traditional technology involving proteins found on coronavirus spike proteins that trigger an immune response.
AstraZeneca Covid Vaccine Protection Wanes After 3 Months: Lancet Study
The findings drawn from datasets in Brazil and Scotland suggest that booster programmes are needed to help maintain protection from severe disease in those vaccinated with AstraZeneca, known as Covishield in India.
EU sets 9-month validity of vaccinations for travel pass
The European Commission on Tuesday adopted rules that will make the European Union Covid-19 certificate valid for travel nine months after the completion of the primary vaccination schedule.
Boosters significantly restore protection vs Omicron, UK says
Booster COVID-19 shots significantly restore protection against mild disease caused by the Omicron variant, in part reversing an otherwise steep drop in vaccine effectiveness, the UK Health Security Agency said on Friday.
Johnson & Johnson Covid Vaccine Can Be Used As Booster: EU Medical Body
A booster dose of Covid-19 vaccine Janssen may be considered at least two months after the first dose in people aged 18 years and above, the European Medicines Agency said.
Can you trust a negative lateral flow Covid test?
Analysis: with cold symptoms, it is better to wait for a PCR result rather than risk spreading the virus
Two jabs offer little protection against Omicron infection, UK data shows
Health agency says booster raises protection as new daily infection figure rises to highest since January
World's largest Covid jab maker forced to halve production
India's Serum Institute, the world's largest vaccine maker, has announced that it is stuck with around half a billion doses of the Covishield jab due to a lack of orders, forcing the company to halve production.
The world has the tools to end the coronavirus pandemic. They're not being used properly
The Covid-19 pandemic will not last forever.
Pfizer accused of ‘sabotaging’ AstraZeneca jab
US drugsmaker Pfizer is denying any wrongdoing after a British TV documentary showed that a presentation made on its behalf had criticized a rival Covid-19 vaccine manufactured by AstraZeneca as being potentially unsafe.
Vaccine ‘side-effects’ might actually be Covid, study warns
Early Covid-19 symptoms mirror vaccine side effects, according to a recent study that warns people who suffer headaches, fatigue, or fever after being jabbed to assume they have been infected, get tested, and isolate themselves.
Anti-vaxxers have made me lose faith in the political right
As someone who has generally identified as a conservative, I’m beginning to lose patience with right-wing politics. There are too many people behaving like they are members of a cult in opposing Covid vaccines.
Too Early To Know If New Covid Variant Needs New Vaccine: EU Medical Body
The EU has reacted with concern to news of the new strain, proposing that member states stop all flights to and from southern African where it was first discovered.
AstraZeneca boasts about UK hospitalizations rate
The chief executive of AstraZeneca has claimed that its Covid-19 vaccine may provide longer protection against the virus and could be responsible for the seemingly lower hospitalisation rate in the UK.
AstraZeneca's pledge to poorer nations as it seeks COVID jab profits from next year
The pharmaceutical company's chief executive defends the company's decision to start making profits from its COVID-19 vaccine, saying that countries with "low purchasing power" will be spared.
COVID-19: AstraZeneca boss on providing vaccine at profit
AZ announced earlier this month that it would be seeking to achieve a modest profit in future from the vaccine In order to fund its new anti-viral COVID treatment.
Load More
×
London Daily
UK
Health
Business
Technology
Add Your News
×
